Sichuan Hexie Shuangma Co., Ltd. manufactures and sells building materials in China, including cement, commercial clinker, and aggregates for infrastructure, industrial parks, municipal projects, commercial housing, urban renewal, and rural revitalization. The company also conducts biopharmaceutical R&D and production, private equity fund management, and peptide API research, production, and customization, including semaglutide, liraglutide, and tilpotide for major chronic diseases. It invests in manufacturing and new energy industries such as photovoltaics, chip design and manufacturing, consumer electronics, intelligent equipment, industrial automation, new energy, autonomous driving, and semiconductor equipment. Formerly known as Sichuan Shuangma Cement Co., Ltd., it changed its name in February 2022, was founded in 1998, and is based in Chengdu, China.